| 000 | 01800 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513125609.0 | ||
| 264 | 0 | _c19971027 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0270-4137 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0045(19971001)33:2<141::aid-pros8>3.0.co;2-n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurphy, G P | |
| 245 | 0 | 0 |
_aEvaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. _h[electronic resource] |
| 260 |
_bThe Prostate _cOct 1997 |
||
| 300 |
_a141-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Surface _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBone Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aBone and Bones _xchemistry |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGlutamate Carboxypeptidase II |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xanalysis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aTroychak, M J | |
| 700 | 1 | _aCobb, O E | |
| 700 | 1 | _aBowes, V A | |
| 700 | 1 | _aKenny, R J | |
| 700 | 1 | _aBarren, R J | |
| 700 | 1 | _aKenny, G M | |
| 700 | 1 | _aRagde, H | |
| 700 | 1 | _aHolmes, E H | |
| 700 | 1 | _aWolfert, R L | |
| 773 | 0 |
_tThe Prostate _gvol. 33 _gno. 2 _gp. 141-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0045(19971001)33:2<141::aid-pros8>3.0.co;2-n _zAvailable from publisher's website |
| 999 |
_c9293992 _d9293992 |
||